Synlogic, Inc. (NASDAQ:SYBX – Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.94 and traded as low as $0.6315. Synlogic shares last traded at $0.66, with a volume of 44,483 shares changing hands.
Synlogic Price Performance
The firm has a fifty day simple moving average of $0.63 and a two-hundred day simple moving average of $0.94. The firm has a market capitalization of $7.72 million, a P/E ratio of -2.54 and a beta of 0.52.
Hedge Funds Weigh In On Synlogic
A number of large investors have recently made changes to their positions in SYBX. Citadel Advisors LLC purchased a new stake in shares of Synlogic in the third quarter worth $49,000. Renaissance Technologies LLC increased its holdings in Synlogic by 116.7% during the 4th quarter. Renaissance Technologies LLC now owns 85,627 shares of the biotechnology company’s stock valued at $96,000 after purchasing an additional 46,117 shares during the period. Finally, DRW Securities LLC purchased a new position in Synlogic during the 4th quarter valued at about $27,000. 63.40% of the stock is owned by institutional investors.
About Synlogic
Synlogic, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout.
See Also
- Five stocks we like better than Synlogic
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Receive News & Ratings for Synlogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synlogic and related companies with MarketBeat.com's FREE daily email newsletter.
